EUCTR2011-005225-40-Outside-EU/EEA进行中（未招募）不适用
A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Dapagliflozin in Children and Adolescents Aged 10 to 17 Years with Type 2 Diabetes Mellitus - PK Study of Dapagliflozin in Pediatric Subjects with T2DM
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Clinical diagnosis of T2DM
- •Male and female subjects ages 10-17
- •HbA1c >6 to <10%
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 24
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Fasting plasma glucose (FPG) > 240 mg/dL at screening
- •Abnormal renal function
- •Active liver disease and/or significant abnormal liver function
研究者
相似试验
进行中（未招募）
1 期
Clinical research study to determine how trazodone can influence the sleep and how it works in the body after one or repeated doses taken by mouth, in children suffering from insomnia and with autism, intellectual disability or attention deficit hyperactivity disorder (ADHD)Insomnia in children and adolescents with autism, intellectual disability or ADHDMedDRA version: 20.0Level: PTClassification code 10022443Term: Insomnia related to another mental conditionSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2018-001166-42-ESAziende Chimiche Riunite Angelini Francesco ACRAF S.p.A (Angelini S.p.A.)36
进行中（未招募）
1 期
Clinical research study to determine how trazodone can influence the sleep and how it works in the body after one or repeated doses taken by mouth, in children suffering from insomnia and with autism, intellectual disability or attention deficit hyperactivity disorder (ADHD)Insomnia in children and adolescents with autism, intellectual disability or ADHDMedDRA version: 20.0Level: PTClassification code 10022443Term: Insomnia related to another mental conditionSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2018-001166-42-ITAZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.36
已完成
2 期
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With AsthmaCTRI/2009/091/000603ovartis HealthCare Pvt Ltd1,500
进行中（未招募）
不适用
A Multi-center, Randomized, Parallel Group, Double-blind, Placebo Controlled Estimation Study to Assess the Efficacy and Safety of Modified Release UK-369,003 in the Treatment of Men with Storage Lower Urinary Tract Symptoms (LUTS) With and Without Erectile Dysfunction (ED) - NDEUCTR2006-006656-35-ITPFIZER350
进行中（未招募）
不适用
A Multi-center, Randomized, Parallel Group, Double-blind, Placebo ControlledEstimation Study to Assess the Efficacy and Safety of Modified Release UK-369,003 inthe Treatment of Men with Storage Lower Urinary Tract Symptoms (LUTS) With andWithout Erectile Dysfunction (ED) - not applicableStorage male lower urinary tract symptoms (LUTS) with and without erectile dysfunction (ED).MedDRA version: 9.1Level: LLTClassification code 10046566Term: Urinary tract disorderEUCTR2006-006656-35-FIPfizer Ltd, Ramsgate Road, Sandwich, Kent. UK350